Expression of androgen receptor and growth factors in premalignant lesions of the prostate.

作者: Maureen E. Harper , Eve Glynne-Jones , Lindy Goddard , Phillip Mathews , Robert I. Nicholson

DOI: 10.1002/(SICI)1096-9896(1998100)186:2<169::AID-PATH164>3.0.CO;2-W

关键词:

摘要: Analysis of growth factors and receptors in putative premalignant lesions prostatic adenocarcinoma should aid our understanding their pathways. Sixty TURP (transurethral resection the prostate) specimens exhibiting atypical adenomatous hyperplasia (AAH) and/or intraepithelial neoplasia (PIN) were assayed by immunohistochemistry for androgen receptor (AR), epidermal factor (EGFR), c-erbB-2, transforming factor-alpha (TGF-alpha), vascular endothelial (VEGF), fibroblast factor-2 (FGF-2), MIB-1, E-cadherin, high molecular weight keratin. Expression these was compared with that co-existing benign (BPH) or adenocarcinoma. Strong AR nuclear staining observed luminal cells, but not basal BPH PIN all carcinomas examined. A similar profile demonstrated secretory epithelium high-grade carcinoma a tendency to higher expression membranous EGFR c-erbB-2 cytoplasmic TGF-alpha, lower levels FGF-2 than low-grade glands. Also, increased rates proliferation, as estimated MIB-1 stained comparison confined layer. AAH resembled neither nor carcinoma. Proliferation virtually absent (MIB-1 expression); both E-cadherin significantly reduced; and, exception FGF-2, other studied absent. The results presented would support role PIN, whilst appear represent quiescent phenotype unlikely progress neoplasia.

参考文章(28)
R. Montironi, C. Magi Galluzzi, L. Diamanti, R. Taborro, M. Scarpelli, E. Pisani, Prostatic Intra-epithelial Neoplasia: Qualitative and Quantitative Analyses of the Blood Capillary Architecture on Thin Tissue Sections Pathology Research and Practice. ,vol. 189, pp. 542- 548 ,(1993) , 10.1016/S0344-0338(11)80363-8
Zagzag D, Angiogenic growth factors in neural embryogenesis and neoplasia. American Journal of Pathology. ,vol. 146, pp. 293- 309 ,(1995)
J. A. Schalken, W. B. Isaacs, P. P. Bringuier, F. M. J. Debruyne, H. F. M. Karthaus, H. E. Schaafsma, G. O. N. Oosterhof, R. Umbas, Decreased E-Cadherin Expression Is Associated with Poor Prognosis in Patients with Prostate Cancer Cancer Research. ,vol. 54, pp. 3929- 3933 ,(1994)
M. E. Harper, L. Goddard, E. Glynne-Jones, D. W. Wilson, M. Price-Thomas, W. B. Peeling, K. Griffiths, An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors The Prostate. ,vol. 23, pp. 9- 23 ,(1993) , 10.1002/PROS.2990230103
ME Harper, E Glynne-Jones, L Goddard, VJ Thurston, K Griffiths, Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells. British Journal of Cancer. ,vol. 74, pp. 910- 916 ,(1996) , 10.1038/BJC.1996.456
J.I. Epstein, Adenosis (Atypical Adenomatous Hyperplasia): Histopathology and Relationship to Carcinoma Pathology Research and Practice. ,vol. 191, pp. 888- 898 ,(1995) , 10.1016/S0344-0338(11)80973-8
M.T. Story, Regulation of prostate growth by fibroblast growth factors. World Journal of Urology. ,vol. 13, pp. 297- 305 ,(1995) , 10.1007/BF00185973
M.E. Harper, L. Goddard, E. Glynne-Jones, W.B. Peeling, K. Griffiths, Epidermal growth factor receptor expression by Northern analysis and immunohistochemistry in benign and malignant prostatic tumours European Journal of Cancer. ,vol. 31, pp. 1492- 1497 ,(1995) , 10.1016/0959-8049(95)00207-Y